Skin and Connective Tissue Diseases: Keloid scars Skin and Connective Tissue Diseases Hypertrophic disorders of skin
Conditions
Interventions
A randomised prospective clinical trial.
Subjects: patients who are scheduled for intralesional injection of their keloid scars
Methods: patients to be randomised into two groups to either receive app
Sponsors
Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
Eligibility
Inclusion criteria
Inclusion criteria: Patients over the age of 18 who are scheduled to receive intralesional steroid injections as part of their treatment for keloid scarring. This will include patients within the Greater London Area.
Exclusion criteria
Exclusion criteria: Does not match inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A visual analogue scale will be completed to and after the steroid injection and the subjects will be asked to rate the pain experienced. Pain scores will then be compared between the groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed